Benitec Biopharma (BNTC) Return on Sales (2019 - 2024)
Benitec Biopharma (BNTC) posted Return on Sales of 568.99% for Q1 2024, down 7331.21% sequentially from 7.66% in Q4 2023, and down 56791.0% YoY from N/an in Q2 2023.
Benitec Biopharma (BNTC) Return on Sales (2019 - 2024) Analysis & Trends
Benitec Biopharma has reported Return on Sales for 6 years, with the latest figure at 568.99% in Q1 2024.
- Quarterly Return on Sales fell 56791.0% year-over-year to 568.99% in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 568.99% (down 56568.0% YoY) and the FY2023 annual result came in at 4.13%, up 78.0% from the prior year.
- Return on Sales slipped to 568.99% in Q1 2024 per BNTC's latest filing, from 7.66% in the prior quarter.
- Over five years, Return on Sales peaked at 4.62% in Q2 2020 and troughed at 568.99% in Q1 2024.
- A 5-year average of 44.13% and a median of 4.53% in 2022 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2022 and 2024: Return on Sales surged 3861 bps in 2022, then plunged 56791 bps in 2024.
- Over 5 years, Return on Sales stood at 35.82% in 2020, then soared by 94 bps to 1.99% in 2021, then tumbled by 127 bps to 4.53% in 2022, then slumped by 69 bps to 7.66% in 2023, then tumbled by 7331 bps to 568.99% in 2024.
- According to Business Quant data, Return on Sales over the past three periods registered 568.99%, 7.66%, and 4.64% for Q1 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -568.99% |
| Dec 31, 2023 | -7.66% |
| Sep 30, 2023 | -4.64% |
| Jun 30, 2023 | -23.48% |
| Mar 31, 2023 | -1.08% |
| Dec 31, 2022 | -4.53% |
| Sep 30, 2022 | -2.59% |
| Jun 30, 2022 | -2.54% |
| Mar 31, 2022 | -0.75% |
| Dec 31, 2021 | -1.99% |
| Sep 30, 2021 | -41.20% |
| Jun 30, 2021 | -20.24% |
| Mar 31, 2021 | -38.01% |
| Dec 31, 2020 | -35.82% |
| Sep 30, 2020 | -0.49% |
| Jun 30, 2020 | 4.62% |
| Mar 31, 2020 | -0.75% |
| Dec 31, 2019 | -0.27% |
| Sep 30, 2019 | -0.35% |